AKVILAFARM, OOO, Moscow

Economic indicators

Net loss (RA) of AKVILAFARM, OOO made up 27.04 million RUB over 2023 compared to net profit of 9.72 million RUB over 2022, the company informed.

Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 207.02 million RUB in 2022.

Net profit (RAS) of AKVILAFARM, OOO dropped in 2022 by 25.59% to 24.77 million RUB from 33.29 million RUB over the same period in 2021, the company informed.

Revenue increased in the accounting period by 36.12% to 207.12 million RUB from 152.15 million RUB over 2021; cost of goods sold grew 1.60 times to 152.88 million RUB from 95.53 million RUB; sales profit fell by 49.05% to 22.07 million RUB from 43.31 million RUB.

Net profit (RAS) of AKVILAFARM, OOO grew over 2021 12.82 times to 33.29 million RUB from 2.60 million RUB over 2020, the company informed.

Revenue increased in the accounting period 22.47 times to 152.15 million RUB from 6.77 million RUB over 2020; cost of goods sold grew 184.42 times to 95.53 million RUB from 518.00 thousand RUB; sales profit went up 9.99 times to 43.31 million RUB from 4.34 million RUB.

Net profit (RAS) of AKVILAFARM, OOO grew over 2020 185.43 times to 2.60 million RUB from 14.00 thousand RUB over 2019, the company informed.

Revenue increased in the accounting period 33.52 times to 6.77 million RUB from 202.00 thousand RUB over 2019; cost of goods sold grew 3.32 times to 518.00 thousand RUB from 156.00 thousand RUB; sales profit went up 103.24 times to 4.34 million RUB from 42.00 thousand RUB.

Companies in the region

• ART DEKO
• STOLITSA
• LOGISTIKA 1520
• PARUS
• KONUS